Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo. Taking two Wegovy doses at the same time is not safe and is not recommended. If you miss a dose or forget when you last injected, you take the next scheduled dose at the correct time — you never double up. Semaglutide is a weekly injection precisely calibrated by your prescriber, and the titration schedule exists for good biological reasons. These are prescription-only medicines that require clinical oversight; decisions about timing and dosing always rest with your prescribing team, not with a judgment call on a Tuesday morning.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's an understandable thought. Progress can feel slow, especially in the first few months at lower doses, and if there's a spare pen sitting in the fridge door you might wonder whether taking both would move things along. It won't, and it's genuinely risky to try.
Semaglutide works by activating GLP-1 receptors that slow gastric emptying, reduce appetite and influence blood-sugar regulation. Even a single standard dose does a great deal in the body over seven days. Taking two doses at once doesn't double the benefit; it dramatically amplifies the side-effect burden. Nausea, vomiting and diarrhoea are the most common reactions reported in clinical trials, typically at their worst when a dose is first introduced or increased. Stacking two injections compresses what should be a careful step-change into a single moment, with no gradual acclimatisation.
The NHS medicines guidance for semaglutide is explicit on this: if you realise you've forgotten a dose and more than five days have passed since it was due, skip it and continue with your normal weekly schedule. If fewer than five days have passed, take the missed dose as soon as you remember. You do not take an extra injection to compensate. That instruction is there for patient safety, not as a formality.
Wegovy treatment begins at 0.25 mg, a dose deliberately chosen because it gives the body time to adapt before stepping up. Each increase through 0.5 mg, 1.0 mg, 1.7 mg and ultimately 2.4 mg (or 7.2 mg for those on the newer maintenance dose, subject to clinical assessment) is spaced roughly four weeks apart for the same reason.
Taking a second pen at any point in that ladder skips the physiological adjustment that the schedule is designed to protect. Clinically, this matters most for the gastrointestinal effects: nausea settles for most people within one to two weeks of a new dose, but that window of settling disappears if you bypass the step entirely.
There are also broader safety considerations. Severe vomiting can cause dehydration serious enough to affect kidney function. Persistent abdominal pain (particularly pain that radiates to the back) should always be assessed promptly, since pancreatitis is a recognised if infrequent side effect of GLP-1 medicines. Taking more than prescribed creates an environment where symptoms are harder to attribute and harder to manage. The MHRA's safety guidance on GLP-1 medicines highlights exactly these concerns; you can report any unexpected reactions at yellowcard.mhra.gov.uk.
Questions about whether you can take a Wegovy shot a day early follow similar logic, small timing adjustments within a day or two are a different situation from doubling up, but both questions deserve a direct answer from your prescriber rather than a guess.
The practical rule is simple. Check the date of your last injection. If the missed dose was due within the last five days, take it now and then continue your usual day the following week. If more than five days have passed, skip that dose entirely and pick up your normal schedule on the next due date, even if that means a two-week gap since your last injection.
Never take two injections in the same week to catch up. Your prescriber set the weekly interval because that is how the medicine is licensed and how it was tested. The STEP 1 trial, which generated the core evidence for semaglutide 2.4 mg and is the foundation of the NICE recommendation for Wegovy, was conducted on this precise weekly schedule; deviating from it is deviating from the evidence base.
If you're unsure about timing, the safest move is to contact your prescribing service before you do anything. At nume, prescriber support is available seven days a week, reach the team here if you have an active prescription with us and something doesn't feel right.
Sometimes the impulse to take an extra dose is actually a signal worth paying attention to. If you're three months into treatment and haven't noticed much difference, or if the current dose feels like it stopped working, those are conversations to have with your prescriber, not problems to solve by self-adjusting. A dose increase, a review of the titration plan, or a conversation about whether Wegovy is the right treatment for you are all legitimate clinical routes.
There's also a separate but related question that comes up often: whether two injections of the 2.5 mg Mounjaro starter dose follow the same rule (they do, doubling any GLP-1 dose is not appropriate without prescriber direction). People also ask whether Wegovy can be taken once a month rather than weekly, which is another scheduling change that needs a proper clinical answer before you act on it. If you're weighing up whether Wegovy suits your situation at all, the BMI criteria for Wegovy is a good starting point, and our team can work through the full picture with you at consultation.
For anyone still deciding between treatment options, the weight-loss treatment overview sets out what's currently licensed in the UK, and a free consultation means a real clinician looks at your full medical history before anything is prescribed. If you're also taking supplements and want to know whether inositol can be used alongside Wegovy, that's worth raising with your prescriber too, since the combination has its own considerations. The cost of that consultation is included, there's nothing to pay to get a proper answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.